Abstract
Many autistic patients with mental retardation have difficulties with explosivity and aggression. They often prove resistant to various pharmacotherapeutic interventions. In this study, 11 male outpatients (mean 18.3 years) were administered risperidone in an open-label fashion. The risperidone was started at 0.5 mg daily, and titrated upwards until maximum clinical benefit occurred. Serial clinical interviews were conducted, and Conners Parent-Teacher Questionnaires (short form) were completed by the caretakers. Substantial clinical improvement was noted almost immediately in each patient, with aggression, self-injury, explosivity, and poor sleep hygiene most improved. The modal dose for optimal response was 0.5 mg bid. Weight gain was a significant side effect (average velocity of 0.47 kg per week), while none of the patients experienced extrapyramidal side effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Addington, D. E., Toews, J. A., & Addington, J. M. (1995). Risperidone and tardive dyskinesia: A case report. Journal of Clinical Psychiatry, 56, 484–485.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
Birmaher, B., Quintana, H., & Greenhill, L. L. (1988). Methylphenidate treatment of hyperactive autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 248–251.
Campbell, M., Anderson, L. T., & Greene, W. H. (1987). Psychopharmacology. In D. A. Cohen, A. M. Donnallan, & R. Paul (Eds.), Handbook of autism and pervasive developmental disorders. New York: Wiley.
Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283–1291.
Chance, W. T., & Fischer, J. E. (1993). Neurotransmitters and food intake. Nutrition, 9, 470–471.
Chouinard, G., & Arnott, W. (1993). Clinical review of risperidone. Canadian Journal of Psychiatry, 38(Suppl. 3), S89–S95.
Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G. W., Labelle, A., Beauclair, L., & Arnott, W. (1993). A Canadian multi-centre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13, 25–40.
Conners, C. K. (1973). Rating scales for drug studies with children. Psychopharmacology Bulletin, 9(Special issue), 24–84.
Cook, E. H., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.
Ferrari, F., & Giuliani, D. (1994). Effect on rat feeding behavior of two selective D2 dopamine agonists. Physiology & Behavior, 56, 921–926.
Gadow, K. D. (1992). Pediatric psychopharmacotherapy: A review of recent research. Journal of Child Psychology & Psychiatry & Allied Disciplines, 33, 153–195.
Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.
Jaselskis, C. A., Cook, E. H., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322–327.
Locascio, J. J., Malone, R. P., Small, A. M., Kafantaris, V, Ernst, M., Lynch, N. S., Overall, J. E., & Campbell, M. (1991). Factors related to haloperidol response and dyskinesias in autistic children. Psychopharmacology Bulletin, 27, 119–126.
Malone, R. P., Ernst, M., Godfrey, K. A., Locascio, J. J., & Campbell, M. (1991). Repeated episodes of neuroleptic-related dyskinesias in autistic children. Psychopharmacology Bulletin, 27, 113–117.
Murray, S., & Haller, E. (1995). Risperidone and NMS? Psychiatric Services, 46, 951.
Najara, J. E., & Enikeev, I. D. (1995). Risperidone and neuroleptic malignant syndrome: A case report. Journal of Clinical Psychiatry, 56, 534–535.
Nass, R., & Koch, D. (1992). Pervasive developmental disorders. In D. M. Kaufman, G. E. Solomon, & C. R. Pfeffer (Eds.), Child and adolescent neurology for psychiatrists (pp. 56–66). Baltimore: Williams and Wilkins.
Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiatry, 39, 400–405.
Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283–294.
Quintana, H., & Keshavan, M. (1995). Case study: Risperidone in children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1292–1296.
Ratey, J. J., Bemporad, J., Sorgi, P., Bick, P., Polakoff, S., O'Driscoll, G., & Mikkelsen, E. (1987). Open trial effects of beta-blockers on speech and social behaviors in eight autistic adults. Journal of Autism and Developmental Disorders, 17, 439–446.
Realmuto, G. M., August, G. J., & Garfinkel, B. D. (1989). Clinical effect of buspirone in autistic children. Journal of Clinical Psychopharmacology, 9, 122–125.
Remington, G. J. (1993). Clinical considerations in the use of risperidone. Canadian Journal of Psychiatry, 38(Suppl. 3), S96–S100.
Rutter, M., & Schopler, E. (1992). Classification of pervasive developmental disorders: Some concepts and practical considerations. Journal of Autism and Developmental Disorders, 22, 459–482.
Scherer, J., Tatsch, K., Schwarz, J., Oertel, W. H., Konjarczyk, M., & Albus, M. (1994). D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects. Acta Psychiatrica Scandinavica, 90, 266–268.
Schopler, E., Reichler, R. J., & Renner, B. R. (1988). The Childhood Autism Rating Scale. Los Angeles: Western Psychological.
Van Bourgondien, M. E., Marcus, L. M., & Schopler, E. (1992). Comparison of DSM-III-R and childhood autism rating scale diagnoses of autism. Journal of Autism and Developmental Disorders, 22, 493–506.
Volkmar, F. R., & Nelson, D. S. (1990). Seizure disorders in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 127–129.
Wong, V. (1993). Epilepsy in children with autistic spectrum disorder. Journal of Child Neurology, 8, 316–322.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horrigan, J.P., Barnhill, L.J. Risperidone and Explosive Aggressive Autism. J Autism Dev Disord 27, 313–323 (1997). https://doi.org/10.1023/A:1025854532079
Issue Date:
DOI: https://doi.org/10.1023/A:1025854532079